{"title": "Treat Liver Cancer with Tiam1, based on Cancer JAMA", "authors": "Wendy Newman Katherine Miller Joseph Price James Riggs Stacie Beasley", "published_date": "01-17-2016", "affiliation": "California Polytechnic State University-San Luis Obispo, School of Global Science, Technology, and Society", "text": "*New information about the best drug for treatment of hepatocellular carcinoma metastasis.<p>CDT thanks to Xianghua Ye, Jian Guan, Qisheng Li, Laiyu Liu, Xiaokang Zheng, Qisheng Li, Xiaokang Zheng, Laiyu Liu, Xiaokang Zheng, Yanchang Wang, Xiaokang Zheng, Yanqing Ding, Yi Ding, and Longhua Chen for sharing the data on Tiam1<p>Background: Hepatocellular carcinoma (HCC) is a disease in the liver where tumours originate from liver cells. There are three main stages of disease: (1) Primary hepatoma (successful occurrence only in the liver), (2) Secondary hepatoma (a secondary metastasis which is caused by the primary cancer or by the consumption of hepatocytes from another vessel), and (3) liver transplantation (dialysis). A histological examination of the hepatocellular carcinoma (HCC) tumour causes the heterogeneous appearance of different stages of the tumour (often varying in size, shape, and shape). To clarify the patient\u00b4s tumor data, there exists question of LGA/HCC involvement due to the localization of localised microscopic metastases in the liver by high level biopsy of samples. (1) The tumor size at time of biopsy can vary by 10-500 cm. (2) Notably, post hoc and retrospective analysis of histological tissue referred to the pathology of the HCC indicates time for emergence of lethal metastases. (3) Previously, it was reported that significant difference exists between acute tumor in situ and metastasis. However, the development of HCC metastasis has a strong correlation with the pathological findings.<p>Link to the table:<p>and<p>Also, as stated above, histological results of Tiam1 in this case can be very favorable, so the greatest motivation of lead author Qi Qin to investigate the clinical and pharmacologic effects of Tiam1 induced tumor apoptosis. The primary goal of Tiam1 induced tumor apoptosis investigation is to determine the mechanisms for its therapeutic benefits.<p>Regarding this clinical trial, the first study was conducted to search for tumor architecture which is effectively considered to be different than metastasis pathophysiology. Notable difference discovered was the metastasis not proximal to the liver as reported by C. Le.3,4; whereas the preclinical LGA/HCC was assessed. Moreover, the LGA/HCC in tumor was most sensitized to Tiam1. Finally, the tumor morphological assessment at time of tumor closure clearly revealed the selective damage in LGA/HCC.<p>Previously the findings were reported to be as follows:<p>a) Recurrent tumor node display correlated with tumor node evolution independently of tumor site. (5)<p>b) But the tumor area actually shrunk in one half by correlating progression with the tumor remyelination after blockade of Tiam1 activity. (6)<p>c) In the study described above, the primary objective was to determine the presence of SNA\u2019s tumor in an enrolled brain tumor. The secondary objective was to search for tumor tumor gene expression across several systems. It is therefore the most recent academic article.<p>Results:<p>1) P. Le\u2019s new research on the light cell activity and metastasis was previously reported in M.S. Yanchang of Virginia Tech, and Conrod of Chen and Randle on the epidermal growth factor and non-epidermal growth factor (CAMF) expressed at Tiam1-induced tumor. In this new study, an investigation was carried out to try to understand the mechanism and also potential therapeutic mechanisms, which explains the favorable clinical data.<p>2) The LGA/HCC was assessed by correlating tumor remyelination after blockade of Tiam1 activity and tumor rearrangement and/or mutation. The LGA/HCC have distinct tumors, and incidence among these two types is multifarious. At time of tumor closure, three out of four tissues showed minimal tumor burden (mean tissue burden, 1,345 grams), and the tumor gene expression was still low (5 kb/cell). (7)<p>3) The tumors detected in tumor samples obtained by surface sampling had known identifiable LGA/HCC lineage and at time of closure approximately 5 out of 5 tumors were also identified as Tiam1-affected. (9)"}